Author Topic: (MS Journal editorial) Emerging safety issues in alemtuzumab-treated MS patients  (Read 40 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 8564
  • MS diagnosed 1980
  • Location: Pacific Northwest

An editorial with cautions about Lemtrada--"Emerging safety issues in alemtuzumab-treated MS patients" in Multiple Sclerosis Journal (August 1, 2019):

https://journals.sagepub.com/doi/full/10.1177/1352458519851219
MS Speaks--online for 13 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

 

Related Topics